Best of IGCS 2022 Annual Global Meeting-Featured Speaker, Dr. Tal Zaks

Video Transcription

Video Summary

In this video, Dr. Tal Zacks, former Chief Medical Officer at Moderna, gives a keynote lecture on the development and potential applications of mRNA vaccines. He discusses the scientific and technological advancements that allowed for the rapid development of the COVID-19 vaccine, highlighting the importance of collaboration and real-world evidence. Dr. Zacks also explores the potential of mRNA technology in the development of cancer vaccines and personalized medicine, noting the challenges and ongoing research in these areas. He emphasizes the need for continued research and clinical trials to demonstrate the clinical utility of mRNA vaccines in cancer treatment. The lecture concludes with a Q&A session, addressing topics such as the impact of emergency use authorization on cancer development strategies and the need for boosters in cancer vaccines. Dr. Zacks also discusses the role of politics in the development and approval process of mRNA vaccines and the importance of transparency and engagement with the public. The video concludes with Dr. Zacks accepting an award on behalf of his colleagues at Moderna for their work in vaccine development. The award is presented by the Gynecologic Oncology Group Foundation.

Keywords

mRNA vaccines

development

applications

scientific advancements

COVID-19 vaccine

collaboration

cancer vaccines